GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CMMB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Chemomab Therapeutics Ltd. stock price on Friday moving between $0.657 and $0.740
(Updated on Apr 19, 2024)

Sell candidate since Apr 15, 2024 Loss -6.85% PDF

The Chemomab Therapeutics Ltd. stock price fell by -2.86% on the last day (Friday, 19th Apr 2024) from $0.700 to $0.680. During the last trading day the stock fluctuated 12.62% from a day low at $0.657 to a day high of $0.740. The price has fallen in 7 of the last 10 days and is down by -15% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -14 thousand shares and in total, 15 thousand shares were bought and sold for approximately $10.47 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 35.26% during the next 3 months and, with a 90% probability hold a price between $0.81 and $1.31 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CMMB Signals & Forecast

There are few to no technical positive signals at the moment. The Chemomab Therapeutics Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.699 and $0.757. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, March 12, 2024, and so far it has fallen -20.93%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Chemomab Therapeutics Ltd. stock

Chemomab Therapeutics Ltd. finds support from accumulated volume at $0.676 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0829 between high and low, or 12.62%. For the last week the stock has had daily average volatility of 12.91%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CMMB) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Chemomab Therapeutics Ltd. to open at $0.692, and during the day (based on 14 day Average True Range), to move between $0.621 and $0.739, which gives a possible trading interval of +/-$0.0586 (+/-8.62%) up or down from last closing price. If Chemomab Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 17.25% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.676 (0.59%) than the resistance at $0.710 (4.46%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Chemomab Therapeutics Ltd. stock A Buy?

The Chemomab Therapeutics Ltd. stock holds several negative signals and despite the positive trend, we believe Chemomab Therapeutics Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.041 Sell Candidate Unchanged

Predicted Opening Price for Chemomab Therapeutics Ltd. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$0.692 ( 1.81%) $0.680

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CMMB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.775 14.00 %
R2 0.744 9.34 %
R1 0.724 6.47 %
Current price: 0.680
Support S1 0.661 -2.85 %
S2 0.641 -5.73 %
S3 0.609 -10.38 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.80 17.65 %
R2 0.750 10.29 %
R1 0.710 4.46 %
Current price 0.680
Support S1 0.676 -0.588%
S2 0.670 -1.47%
S3 0.580 -14.71%

FAQ

What is the symbol for Chemomab Therapeutics Ltd. Stock and on which exchange is it traded?
The symbol for Chemomab Therapeutics Ltd. is CMMB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Chemomab Therapeutics Ltd. Stock?
The Chemomab Therapeutics Ltd. stock holds several negative signals and despite the positive trend, we believe Chemomab Therapeutics Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Chemomab Therapeutics Ltd. Stock?
Chemomab Therapeutics Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Chemomab Therapeutics Ltd. Stock.

What's the current price of Chemomab Therapeutics Ltd. Stock?
As of the end of day on the 2024-04-19, the price of an Chemomab Therapeutics Ltd. (CMMB) share was $0.680.

What is the 52-week high and low for Chemomab Therapeutics Ltd. Stock?
The 52-week high for Chemomab Therapeutics Ltd. Stock is $1.89 and the 52-week low is $0.420.

What is the market capitalization of Chemomab Therapeutics Ltd. Stock?
As of the 2024-04-19, the market capitalization of Chemomab Therapeutics Ltd. is 9.224M.

When is the next earnings date for Chemomab Therapeutics Ltd.?
The upcoming earnings date for Chemomab Therapeutics Ltd. is May 09, 2024.
Click to get the best stock tips daily for free!

About Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd. Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and cha... CMMB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT